TCL Archive Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board February 3, 1989
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award April 2, 1993
